Skip to main content
OSTEOPORE LIMITED logo

OSTEOPORE LIMITED — Investor Relations & Filings

Ticker · OSX ISIN · AU0000053324 ASX Manufacturing
Open in API
Filings indexed 487 across all filing types
Latest filing 2025-05-07 Board/Management Inform…
Country AU Australia
Listing ASX OSX

About OSTEOPORE LIMITED

https://osteopore.com

Osteopore Limited specializes in the design and manufacture of 3D-printed bioresorbable implants. The company utilizes a patented 3D printing process to create scaffolds from bioresorbable polymers, such as polycaprolactone, designed to mimic the natural microstructure of bone. These implants, including the Osteoplug, Osteomesh, and Osteostrip product lines, are applied in neurosurgical, craniofacial, and orthopedic procedures to facilitate bone healing and tissue regeneration. The scaffolds provide a temporary structural framework that supports the body's natural healing process before being gradually absorbed and replaced by the patient's own bone tissue. This technology aims to reduce long-term complications associated with permanent foreign implants by promoting natural tissue integration and restoration across various clinical applications.

Recent filings

Filing Released Lang Actions
Osteopore Non-Executive Director to step down from Board 3 pages 185.6KB
Board/Management Information Classification · 95% confidence The document is an ASX announcement dated 8 May 2025 regarding a Non-Executive Director stepping down from the Board of Osteopore Limited. It discusses the withdrawal of a resolution at the upcoming AGM and the director's retirement effective 29 May 2025. The content focuses on board membership changes and does not contain financial statements, earnings data, or detailed report content. It is not a full annual report, audit report, or earnings release. The document is clearly about management/board changes, specifically a director stepping down, which fits the Board/Management Information category (MANG). The document length is 4364 characters, which is short but contains substantive information about board changes, not just a brief notice or report publication announcement. Therefore, the appropriate classification is MANG with high confidence.
2025-05-07 English
Change in substantial holding 3 pages 793.1KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001 Section 671B, titled 'Notice of change of interests of substantial holder.' It details changes in voting power and relevant interests of a substantial shareholder in a company, including dates, share counts, and nature of changes. This form is a regulatory filing used to notify the market and regulators about changes in substantial shareholdings. It is not a financial report, earnings release, or management report, nor is it related to board changes, dividends, or capital changes. It fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2025-05-06 English
Becoming a substantial holder 3 pages 59.7KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under the Corporations Act 2001 Section 671B. It details the substantial shareholding of Advance Opportunities Fund in Osteopore Limited, including voting power, relevant interests, registered holders, and consideration paid. The form is regulatory in nature, notifying the market and regulators of a change in substantial shareholding. It is not a financial report, earnings release, or management discussion. It is a specific notification about major shareholding changes, which fits the definition of Major Shareholding Notification (MRQ). The document length is 8868 characters, containing full details rather than a brief announcement, confirming it is the substantive filing of the shareholding notification.
2025-05-06 English
Osteopore strengthens Thailand craniofacial distribution 4 pages 233.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 6 May 2025 about Osteopore Limited entering into a 2-year exclusive distribution agreement with Peakmed Co., Ltd for craniofacial implants in Thailand. The content focuses on the business development and distribution agreement, market potential, and company strategy. There are no financial statements, earnings data, or detailed financial analysis present. The document is a corporate announcement about a capital/financing or business development update rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. The best fitting category is Capital/Financing Update (CAP) as it relates to a significant business agreement impacting the company's distribution and market expansion, which is a form of capital or business update.
2025-05-05 English
Employee Securities Incentive Plan 57 pages 827.0KB
Regulatory Filings Classification · 95% confidence The document is titled 'Employee Securities Incentive Plan' for Osteopore Limited and contains detailed provisions, definitions, and rules related to an employee securities incentive plan. It includes sections on eligibility, grant of securities, vesting, exercise, forfeiture, rights attaching to plan shares, administration, and amendments to the plan. There is no indication that this is a financial report, earnings release, or regulatory filing announcement. Instead, it is a detailed plan document outlining the terms and conditions of an employee incentive scheme involving securities. Such documents are typically classified under governance or regulatory filings related to share plans. However, given the specific nature of the document as a plan rather than a governance report or a proxy solicitation, and it does not fit the other categories like remuneration or capital changes, the best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not neatly fit elsewhere.
2025-05-05 English
Application for quotation of securities - OSX 6 pages 18.3KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) announcement used for the application for quotation of securities. It details the issuance and quotation of new securities resulting from the exercise of options or conversion of convertible notes. The document includes specifics such as the number of securities, issue date, and class of securities. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement related to capital changes and securities quotation. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is the announcement itself, not a brief notice or a report publication announcement.
2025-05-05 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.